Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT
about
Serotonin synthesis, release and reuptake in terminals: a mathematical model5-HT(1A) receptor function in major depressive disorderReciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents50 years of hurdles and hope in anxiolytic drug discoveryS 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamineCerebral 5-HT release correlates with [(11)C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex.Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation.Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT)Serotonin autoreceptor function and antidepressant drug action.Regulation of serotonin release by GABA and excitatory amino acids.The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.Neuropharmacology of venlafaxine.Molecular ontogeny of major neurotransmitter receptor systems in the mammalian central nervous system: norepinephrine, dopamine, serotonin, acetylcholine, and glycine.Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter.5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response.Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxietyAntagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the ratCitalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors.Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats.Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptorsDiphtheria toxin treatment of Pet-1-Cre floxed diphtheria toxin receptor mice disrupts thermoregulation without affecting respiratory chemoreception.Evidence for topographically organized endogenous 5-HT-1A receptor-dependent feedback inhibition of the ascending serotonin systemDSP-1053, a novel serotonin reuptake inhibitor with 5-HT1A partial agonistic activity, displays fast antidepressant effect with minimal undesirable effects in juvenile rats.Genetic Variations in the Serotonergic System Mediate a Combined, Weakened Response to SSRI Treatment: A Proposed Model(1,2)Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype.Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy.Monitoring serotonin signaling on a subsecond time scale.Panic disorder: is the PAG involved?Serotonergic modulation of face-emotion recognition.Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant.Molecular imaging as a guide for the treatment of central nervous system disordersSubanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.Inhibition of bladder overactivity by duloxetine in combination with foot stimulation or WAY-100635 treatment in cats.Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function.Optogenetics enlightens neuroscience drug discovery.Acute selective serotonin reuptake inhibitors regulate the dorsal raphe nucleus causing amplification of terminal serotonin releaseAdjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.
P2860
Q21245218-956C85B7-2D5D-411D-83EB-B182D18BBE2EQ24643511-827AB7F3-6AF0-4F45-9F7B-C7644B795A43Q28140526-7C777F7F-4EEF-4799-8D50-DE68C0A42929Q28297569-78192A8C-225F-4407-AE20-ECAF77DF8C0AQ28343737-C7F0AA79-515C-4F47-818D-A6670EB08735Q30303267-698F12CA-79CD-468C-9312-55487F4857D3Q31832284-4A277CB3-0E97-4D9E-9AF2-8C487D00208CQ32134305-7B9A46A9-616D-4C9F-AE07-B55CF0F0E383Q33690754-4FABD3E8-5142-4635-991C-4424C1D1536EQ33909057-3FB394CA-716E-432E-85F9-12D62183C9DCQ33965264-3F028F2C-443D-4739-A0A7-E2E764C773CDQ33976127-6D752BC6-077F-4D5E-8EE6-025CF7660B5EQ34093686-4A12CC61-0E97-4396-8A98-03D5DC607591Q34238346-2C8AD57A-0E9F-47BD-B0F4-A73B05603C8EQ34621173-454F048D-8B26-41B8-AB97-F9295EC4544CQ34982504-25F1ED8C-066C-4303-8B3F-2FEF4744922AQ35008700-E7B41633-4123-4275-AA8C-56A0F7DB7DBFQ35027188-61249969-348D-4856-9F7B-6670AF669659Q35027871-B457D408-4DA2-498A-8059-8EB7FEAE2EB4Q35027938-D25CB275-7556-459F-8E13-64DD0F6F290CQ35041427-DF40BA40-34D2-48B4-ABCA-FA35D91676B6Q35047176-22379A47-32AE-4DD5-A548-BC8D75420534Q35647163-936DD990-1898-410A-AF7D-F4ACFA1BED92Q35709389-D92EBF4A-89B3-4D52-BCCC-4F098BD4FA48Q35822361-38AE4F19-06DF-4B2C-B03C-DF92EC3546DCQ36103263-DE48FAB6-41B1-4060-A0EB-5BE1594BD06FQ36648936-906061F7-8C90-4837-BB63-B232EB96B0B4Q36879560-CDAA2F66-0A7F-4D55-8129-C146DCCCAB22Q36903011-8025C89B-EEE7-4163-A19F-C65A2B3B2A84Q37124898-16F46000-94E4-4F83-ADB5-CE2A5A822DE0Q37129975-697280F9-4530-4073-9586-B08581AC7AC1Q37230927-1321CDCF-827F-4A40-9F82-E25BB2C3FE75Q37262953-71260CAF-1F6B-4E1E-AE6C-269ABAC61AF0Q37309756-2A5CC8B4-6120-4E32-B865-9E821C42062EQ37440147-9616C66D-A5C7-4BA7-960F-9EC0281DE296Q37508942-FAC59444-0B33-401B-BD56-576E3F630A31Q37591142-77B6E610-0CB2-4175-B5F4-FCC902554FA7Q38650124-EFA17535-B44A-419F-AA99-F33C12D17AE4Q38922620-8764F41F-A964-4BB8-920B-0ED13DA5D927Q38969500-3CE83495-2918-4452-AB06-917D7D24F0CC
P2860
Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Interaction between a selectiv ...... firing and extracellular 5-HT
@en
Interaction between a selectiv ...... firing and extracellular 5-HT
@nl
type
label
Interaction between a selectiv ...... firing and extracellular 5-HT
@en
Interaction between a selectiv ...... firing and extracellular 5-HT
@nl
prefLabel
Interaction between a selectiv ...... firing and extracellular 5-HT
@en
Interaction between a selectiv ...... firing and extracellular 5-HT
@nl
P2860
P1476
Interaction between a selectiv ...... firing and extracellular 5-HT
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1995.TB15919.X
P407
P577
1995-07-01T00:00:00Z